Dr. Dunn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
213 Quarry Road
Palo Alto, CA 94304Phone+1 650-736-4310Fax+1 650-725-0390- Is this information wrong?
Summary
- Dr. Jeffrey Dunn is a neurologist in Palo Alto, CA and is affiliated with Stanford Health Care. He received his medical degree from Temple University School of Medicine and has been in practice 28 years. He specializes in neuroimmunology/multiple sclerosis and is experienced in neuroimmunology (multiple sclerosis).
Education & Training
University of WashingtonResidency, Neurology, 1990 - 1993
Lewis Katz School of Medicine at Temple UniversityClass of 1989
Haverford CollegeBA, French Literature, 1979 - 1983
Certifications & Licensure
CA State Medical License 2008 - 2025
WA State Medical License 1990 - 2008- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis Start of enrollment: 2024 Apr 10
- Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) Start of enrollment: 2019 Dec 19
Publications & Presentations
PubMed
- Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma.Esther H Nie, Yi-Jiun Su, John H Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H Han, Jeffrey E Dunn, Lucas B Kipp, David B Mi...> ;Blood Advances. 2024 Mar 26
- 2 citationsBiomarker panel increases accuracy for identification of an MS relapse beyond sNfL.Saurabh Gawde, Agnieshka Agasing, Neal Bhatt, Mackenzie Toliver, Gaurav Kumar, Kaylea Massey, Andrew Nguyen, Yang Mao-Draayer, Susan Macwana, Wade DeJager, Joel M Guth...> ;Multiple Sclerosis and Related Disorders. 2022 Jul 1
- 89 citationsKIRCD8T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19.Jing Li, Maxim Zaslavsky, Yapeng Su, Jing Guo, Michael J Sikora, Vincent van Unen, Asbjørn Christophersen, Shin-Heng Chiou, Liang Chen, Jiefu Li, Xuhuai Ji, Julie Wilh...> ;Science. 2022 Apr 15
- Join now to see all
Authored Content
- Clonally expanded B cells in Multiple Sclerosis bind EBV EBNA1 and GlialCAMJanuary 2022
Press Mentions
‘Military Police’ Cells Arise to Arrest Infection-Induced Autoimmunity, Study FindsMarch 8th, 2022
Annual Awards Honor Outstanding Teaching, Patient CareJune 22nd, 2017
Stanford Neuroscience Health Center Opens to Patients TodayJanuary 11th, 2016- Join now to see all
Committees
- Chair, MS Section American Academy of Neurology 2018 - Present
- NMSS, National Medical Advisory Board 2018 - Present
Research History
- Principal InvestigatorProject BIG: The Brain, Immune & Gut Research Initiative to find the cause and cure of Multiple Sclerosis2018 - Present
Professional Memberships
- Fellow
Hospital Affiliations
Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
